Insmed (INSM) Gross Profit (2018 - 2026)
Insmed's Gross Profit history spans 9 years, with the latest figure at $258.5 million for Q1 2026.
- Quarterly Gross Profit rose 261.37% to $258.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $670.5 million through Mar 2026, up 130.04% year-over-year, with the annual reading at $483.5 million for FY2025, 73.94% up from the prior year.
- Gross Profit came in at $258.5 million for Q1 2026, up from $219.6 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $258.5 million in Q1 2026 to a low of $40.9 million in Q1 2022.
- The 5-year median for Gross Profit is $65.2 million (2023), against an average of $85.3 million.
- Year-over-year, Gross Profit rose 7.93% in 2022 and then skyrocketed 261.37% in 2026.
- Insmed's Gross Profit stood at $46.2 million in 2022, then skyrocketed by 41.14% to $65.2 million in 2023, then increased by 19.99% to $78.3 million in 2024, then surged by 180.52% to $219.6 million in 2025, then increased by 17.72% to $258.5 million in 2026.
- Per Business Quant, the three most recent readings for INSM's Gross Profit are $258.5 million (Q1 2026), $219.6 million (Q4 2025), and $113.0 million (Q3 2025).